![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1232, 2000-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Identifying who is high risk after MI: N-BNP levels or echocardiography?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 286, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The ELITE Study: What are its Implications for the Drug Treatment of Heart Failure?
By Aronow W.S.
Drugs & Aging, Vol. 12, Iss. 6, 1998-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Start statins stat for patients with heart failure?
Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oral glucocorticoid use a risk factor for heart failure?
Inpharma, Vol. 1, Iss. 1453, 2004-01 ,pp. :